AMETEK, Inc. (AME)
Last Price$186.6(1.5%)
Market Cap$43.8B
AME Rating
AME Quality rating performance
AME Intrinsic Value
Key Highlights:
As of Mar 03, 2025 AME Relative Value is $184.6, which is overvalued by 1.0%, compared to current share price of $186.6.
As of Mar 03, 2025 AME DCF Value is $96.2, which is overvalued by 48.4%, compared to current share price of $186.6.
AME Share Price History
1W 0.4%
1M 1.3%
6M 12.3%
YTD 15.3%
1Y 3.7%
3Y 45.2%
5Y 120.9%
10Y 272.7%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
AME Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$43.8B
$44.1B
$6,941.2M
$1,203.5M
Shares Outstanding
235M
Employees
N/A
Growth (CAGR)
6.1%
9.48%
19.52%
Profitability
51.8%
25.6%
19.8%
18.4%
17.3%
87.5%
Intrinsic Value
$138.4 (25.8% overvalued)
$95.7
$181.0
$135.6
36.0%
Return on Capital
Financial Health
$280.3M
0.2x
25.8x
Dividends
9.2%
0.4%
16.1%
Dec 06, 2024
Earnings
Apr 30, 2025
MISS by (0.1%)
BEAT by 2.4%
(10.3%)
10 Beat & null Miss
AME Stock Financials
AME Income Statement Metrics
Annual
Quarterly
LTM
AME Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$1,735.3M +51.0% YoY
Capital Expenditure (CAPEX)
($136.2M) -2.0% YoY
Free Cash Flow (FCF)
$1,599.0M +58.3% YoY
AME Income Statement Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
$6,597.0M 7.3% YoY
Cost of revenue
$4,212.5M 5.2% YoY
Pre-tax income
$1,606.4M 12.4% YoY
24.4% margin
AME Balance Sheet Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$15.0B
Current assets ($2,824.7M, 18.8% of total)
$409.8M (2.7%)
$1,012.9M (6.7%)
Other current assets
$1,401.9M (9.3%)
Non-current assets ($12.2B, 81.2% of total)
$11.9M (0.1%)
$1,121.0M (7.5%)
$4,165.3M (27.7%)
Other non-current assets
$6,900.6M (45.9%)
Financial position
$2,964.6M
Cash & Short-term
Investments
Total Debt
AME Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
AME Earnings Surprises
Crunching data... Almost there!
AME Dividends
AME Dividend Yield
Crunching data... Almost there!
AME Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with AME
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$43.8B | 6.3 | $138.4 25.8% overvalued | 3.7% | $6,941.2M | $1,203.5M | 5.2% | 17.3% | 51.8% | 11.0% | 5.9% | |
$113.4B | 6.9 | $166.8 40.1% overvalued | (4.9%) | $24.9B | $2,730.0M | 7.3% | 11.0% | 53.5% | 26.3% | 53.0% | |
$85.5B | 6.4 | $480.6 26.1% overvalued | 22.5% | $19.9B | $3,298.6M | 0.4% | 16.6% | 35.8% | 5.2% | 63.6% | |
$78.1B | 6.4 | $214.9 18.1% overvalued | 3.6% | $15.9B | $2,844.0M | (1.3%) | 17.9% | 44.1% | 27.7% | 243.5% | |
$68.7B | 6.4 | $106.9 8.8% overvalued | 8.5% | $17.6B | $3,269.0M | 10.3% | 18.6% | 43.3% | (2.0%) | 20.8% | |
$63.3B | 5.9 | $585.7 0.0% overvalued | 7.7% | $7,039.2M | $2,293.8M | 13.9% | 32.6% | 69.3% | 5.3% | 0.0% | |
$55.1B | 7.4 | $58.7 55.2% overvalued | 93.7% | $7,430.0M | $977.0M | 11.9% | 13.1% | 46.6% | 16.7% | 0.1% | |
$50.6B | 6.2 | $554.4 55.8% undervalued | 33.4% | $34.1B | $279.0M | 0.1% | 0.8% | 24.6% | 14.6% | 59.3% | |
$40.4B | 6.1 | $106.3 5.5% undervalued | 6.9% | $14.3B | $1,437.0M | 0.4% | 10.1% | 48.1% | 30.2% | (182.4%) | |
$33.8B | 6.6 | $55.9 32.3% overvalued | (9.7%) | $7,235.0M | $1,377.6M | 5.2% | 19.0% | 42.6% | 7.5% | 0.0% | |
$32.6B | 5.7 | $183.8 34.0% overvalued | (1.9%) | $6,934.1M | $967.4M | (24.0%) | 14.0% | 45.3% | 13.1% | 104.1% |
FAQ
What is AMETEK, Inc. (AME) stock rating?
As of today, AMETEK, Inc. has a stock rating of 6 (out of 10), which is considered Good.
is AMETEK, Inc. (AME) a good stock to buy?
As of today, AMETEK, Inc. has a Good stock rating, which is 25.8% overvalued. According to Value Sense backtesting, stocks with similar profile tend to underperform the market by 4.6%.